[1]
2025. Impact of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors on Cardiovascular Events in Type 2 Diabetes. Indus Journal of Bioscience Research. 3, 1 (Jan. 2025), 320–324. DOI:https://doi.org/10.70749/ijbr.v3i1.496.